From NCPA website, Dec. 10: A coalition of national pharmacy groups has applauded the latest version of the bipartisan Prescription Drug Pricing Reduction Act, released on Dec. 6 by the Senate Finance Committee; the pharmacy groups say the bill addresses backdoor clawback fees charged by large pharmacy benefit managers (PBMs) that are shuttering pharmacies and costing patients more at the pharmacy counter.